Celebrating our 10th anniversary – Unlock our special offer today
LATEST ALERTS
The Canadian cannabis retailer High Tide has made a move into the UK CBD sector by purchasing 80% of the Scottish CBD company Blessed CBD for just over £9m
Does the CBD industry now face increased scrutiny from the US Securities and Exchange Commission (SEC)?
Zimbabwe wants to be a big player in the African cannabis industry, but the country is failing to meet its initial ambitions because only a few licensed companies are active
Patience continues to be the watchword when it comes to innovation in the cannabinoid beverage space. Developments continue but companies appear willing to take their time to enter the market as regulation loosens
A UK cannabis firm reached its minimum crowd-funding target of £3.2m ($4.4m) in just one hour. And the investment keeps on coming
A Nordic company making functional ingredients from mushrooms is looking for €3m in Series A investment in order to scale up its production capacity to meet demand
A plan to solve issues with cannabis e-commerce has attracted investors to the tune of around $130m in total
Discount supermarket chain Lidl has removed foods containing hemp from its stores in Germany, Ireland and the Netherlands amid concerns that the products contain excessive levels of THC
GenCanna continues to bet on the future of UK bulk and white label CBD products with the purchase of another company specialising in those areas
NFL veteran Chris Hetherington has launched a CBD oil derived entirely from orange peel, describing it as “crystalline CBD at a purity and consistency difficult to match with cannabis or hemp-derived material”
A $545m deal to buy the company Gage Growth will give North American cannabis operator TerrAscend access to the cannabis market in the US state of Michigan
The makers of a new CBD pain relief cream – mixed with an actual local anaesthetic – are bullish about their prospects of a sales boost from an endorsement deal with one of the most painful professional sports around
CBD beverages continue to be a popular niche sub-category for producers, with brands still experimenting and bringing out new variations. Some significant regulatory concerns remain for the mid/long-term. Neither the US, UK or EU has explicitly permitted CBD to be used as an ingredient for a beverage or any other ingestible product. And there is growing concern that – given » Continue Reading.
There are always people claiming that new changes mean some such country will be “The next big X in cannabis or hemp”. Recent examples include North Macedonia, Thailand, Brazil, Paraguay, Lesotho, Malawi, and of course, Colombia
Cult favourite Jones Soda will enter the US cannabis beverage market, while an Oklahoma firm’s new beverage launch looks well positioned to capitalise on any move to a recreational market in the state
A recent ring trial assessment of the lab performances and methods for measuring CBD in commercial products has given some good news to the industry
New funding raised from investors will propel cannabis company expansion and research
US cannabis businesses continue to expand their presence into new states through mergers and acquisitions
A range of Bob Marley themed functional mushroom tinctures will soon debut in the UK under the Marley One brand
A Canadian cannabis retailer is banking on boosts from cross-selling and increased social media presence to buoy US sales as it gobbles up accessory providers
London-based AltoVerde has chosen North Macedonia as its site for growing medical cannabis to be sold throughout European markets
The Canadian pyschedelics company MagicMed will be taken over by the US firm Enveric Biosciences in a move that will create greater research and development as well as commercialisation opportunities
A year and eight months after Cibdol submitted its novel food application for EU authorisation of synthetically produced CBD, the Swiss company is still fielding questions from the European Food Safety Authority (ESFA)
The European Commission (EC) has validated a novel food application submitted by the Italian company Farmabios for a synthetic CBD. This is the first step to gaining novel food authorisation from the European Food Safety Authority (EFSA). The company said it had also submitted a similar dossier to the UK Food Standards Agency (FSA) and expects to receive validation there » Continue Reading.
CBD-infused drinks company Trip is making its way into the US after it raised $5m (£3.6m) in a Series A funding round last month
Brand creation and consolidation is driving a number of major business deals in the US market
Nordic Oil’s announcement of a crowd-funding launch on Seedrs is the latest in a growing queue of crowd-funding announcements. There are several reasons why even large CBD brands are increasingly turning towards crowd-funding as a method for raising funds. The most obvious is that it remains difficult for them to agree terms with more traditional funders. Banks and even government » Continue Reading.
Appetite for European ingredients producers appears to be driving the latest round of merger and acquisition (M&A) action in the cannabinoid sector
Nordic Oil could become the largest European CBD brand to raise money through crowd-funding as it seeks to raise €3m-€5m through the Seedrs platform
CBD and cannabis startups from Scotland to Florida are attracting increasing numbers of investors as they scale up their businesses and break crowd-funding records in the process
UK venture capital fund Neo Kuma has invested £5m across seven healthcare companies focused on the use of psychedelics to help combat mental health issues
A new UK cannabis industry association claims to be the first to bring together members from every aspect of the industry – with a range of more than 100 members already
Canadian cannabis retailer High Tide is continuing its advance into the US market with the $26m acquisition of 80% of CBD e-commerce platform Fab Nutrition (FAB CBD)
The UK alcohol industry’s voluntary regulator denies being outright opposed to CBD alcoholic drinks – but moves made by one major brand suggests many see the writing on the wall for the niche sector
Merger and acquisition activity remains high in the industry and two major Canadian firms – Sundial Growers and Canopy Growth – have made acquisitions this month
The boss of the world’s new largest global cannabis company has likened the industry’s potential to that of the alcohol business before the ending of Prohibition in the early 1930s
CBD-Intel’s opinion from a reading of laws at the federal level is that – currently – delta-8 THC should be considered legal if derived from a legal hemp plant. This is because the federal definition of hemp encompasses multiple parts including cannabinoids, derivatives and isomers and shields them from the federal definition of tetrahydrocannabinols listed in Schedule I of the » Continue Reading.
CBD-Intel’s new UK online report highlights a number of interesting market developments. Among them is the information that brand distribution provides. From a dominance perspective, more brands are now being listed for cosmetic than vape products. This shows how cosmetics now have more exposure to the wider population by having a more diverse range of brand offerings along with greater » Continue Reading.
US cannabis firm Trulieve has bought Harvest Health and Recreation in a $2.1bn deal that aims to create the US’s most profitable cannabis company in what is being billed as the largest US cannabis transaction to date
Two US firms, Greenlane and KushCo, have merged in a deal that aims to create a major manufacturer and distributor of cannabis accessories in the US
Recent consultation guidance does suggest that the USPS is considering broadly exempting hemp and CBD services from the incoming rule. The guidance states: “For hemp-based products containing CBD with a THC concentration not exceeding 0.3 percent, mailers must retain, and prepare to make available upon request, records establishing compliance with all applicable federal, state, and local laws pertaining to hemp » Continue Reading.
When Biden won the US election in November 2020 the stock market value of cannabis firms soared in expectation of a more lenient political climate under the Biden administration
Various business deals across the US and Canada see cannabis and CBD companies expanding their portfolios and growing their brands in a series of acquisitions, investments and partnerships
Minor cannabinoids are gaining increasing interest – pushed by both slowly growing consumer awareness and companies looking to develop further revenue streams from under-utilised products. A number of claims have been made about the properties of various minor cannabinoids – some skirting dangerously close to the line of what is currently permitted and some going well over that health claims » Continue Reading.
It does not look like good news. The only two companies (controlling three brands that contain 23 individually listed products) included in the initial list of validated applications both say they submitted their applications to the FSA in early January. Both also are at least partly based on synthetic CBD ingredients that have successfully navigated EU novel food application initial » Continue Reading.
Australian medicinal cannabis firm Cann has moved quickly to maximise the benefits of its CBD Gelpell capsule technology by entering into a collaboration deal with healthcare technology firm Emyria
Jersey could become “a cannabis hub for Europe” after Northern Leaf successfully completed a second round of funding that will enable it to complete its pharmaceutical cannabis cultivation facility on the island
Access to banking services has been a problem for the legal cannabis sector in the US from the beginning – and the experience of one cooperative in Michigan shows that the relationship can be problematic for financial institutions too
Canadian cannabis firm Tilray is moving in on New Zealand’s market for medical cannabis and has received the necessary approvals to launch Tilray medical cannabis products across the country
From a consumer/market perspective, it certainly looks like delta-8 THC is the most promising minor cannabinoid. It has quickly overtaken others such as CBG and CBN in terms of general awareness and – anecdotally – in terms of interest from companies and consumers alike. The appeal appears to be that it acts as a “lighter” version of delta-9 THC – the more typical psychoactive element » Continue Reading.
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
